NCT04372914View on ClinicalTrials.gov

Prevention of Oral DNA Damage by Black Raspberries

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 7, 2021

Primary Completion Date

December 6, 2024

Study Completion Date

December 6, 2024

Conditions

Oral CancerSmokingDNA DamageOxidative Stress

Interventions

DIETARY_SUPPLEMENT

BRB Lozenges

Each lozenge is made from 1 gram of freeze-dried black raspberry powder (equivalent to \~5 black raspberries) in the form of a dissolvable slow-release lozenge.

Trial Locations (1)

17033

Penn State CTSI Clinical Research Center, Hershey

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Milton S. Hershey Medical Center

OTHER

NCT04372914 - Prevention of Oral DNA Damage by Black Raspberries | Biotech Hunter | Biotech Hunter